- Home
- VLN vs FULC Comparison
VLN vs FULC Comparison
Compare VLN & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLN
- FULC
- Stock Information
- Founded
- VLN 2006
- FULC 2015
- Country
- VLN Israel
- FULC United States
- Employees
- VLN N/A
- FULC N/A
- Industry
- VLN Semiconductors
- FULC Biotechnology: Pharmaceutical Preparations
- Sector
- VLN Technology
- FULC Health Care
- Exchange
- VLN Nasdaq
- FULC Nasdaq
- Market Cap
- VLN 208.5M
- FULC 221.5M
- IPO Year
- VLN N/A
- FULC 2019
- Fundamental
- Price
- VLN $3.20
- FULC $4.03
- Analyst Decision
- VLN Strong Buy
- FULC Hold
- Analyst Count
- VLN 1
- FULC 10
- Target Price
- VLN $4.00
- FULC $7.44
- AVG Volume (30 Days)
- VLN 1.0M
- FULC 911.1K
- Earning Date
- VLN 02-26-2025
- FULC 02-25-2025
- Dividend Yield
- VLN N/A
- FULC N/A
- EPS Growth
- VLN N/A
- FULC N/A
- EPS
- VLN N/A
- FULC N/A
- Revenue
- VLN $63,134,000.00
- FULC $80,871,000.00
- Revenue This Year
- VLN N/A
- FULC $2,821.96
- Revenue Next Year
- VLN $28.12
- FULC N/A
- P/E Ratio
- VLN N/A
- FULC N/A
- Revenue Growth
- VLN N/A
- FULC 2987.86
- 52 Week Low
- VLN $1.67
- FULC $2.86
- 52 Week High
- VLN $3.50
- FULC $13.70
- Technical
- Relative Strength Index (RSI)
- VLN 69.88
- FULC 42.71
- Support Level
- VLN $3.22
- FULC $3.90
- Resistance Level
- VLN $3.50
- FULC $5.17
- Average True Range (ATR)
- VLN 0.23
- FULC 0.27
- MACD
- VLN 0.03
- FULC -0.11
- Stochastic Oscillator
- VLN 80.00
- FULC 7.47
About VLN Valens Semiconductor Ltd.
Valens Semiconductor Ltd is a provider of semiconductor products, pushing the boundaries of connectivity by enabling long-reach, high-speed video, and data transmission for the audio-video and automotive industries. It operates in two segments: Audio-Video, which includes the company's HDBaseT solutions for the Audio-Video market deliver superior, plug-and-play convergence and distribution of different interfaces, through a single long-distance category cable; and Automotive segment products enable safe and resilient high-speed in-vehicle connectivity for car architectures, realizing the vision of connected and autonomous cars. The company's geographical revenue is derived from Hungary.
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.